Add office photos
Employer?
Claim Account for FREE
Biocon Limited
3.9
based on 2k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Biocon Limited
Company Summary
We are a global biopharmaceutical company changing patients’ lives in over 120 countries by finding new and affordable ways to treat diabetes, cancer and autoimmune diseases.
Overall Rating
3.9/5
based on 2k reviews
On-Par with
industry average
Highly rated for
Job security, Work-life balance
Critically rated for
Promotions
Work Policy
Work from office
82% employees reported
Monday to Saturday
40% employees reported
Flexible timing
81% employees reported
No travel
56% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
2 employees reported
Child care facility
2 employees reported
Office gym
2 employees reported
Cafeteria
2 employees reported
View all benefits
About Biocon Limited
Founded in1978 (47 yrs old)
India Employee Count1k-5k
Global Employee Count5k-10k
India HeadquartersBangalore Rural, Karnataka, India
Office Locations
--
Websitebiocon.com
Primary Industry
Other Industries
Are you managing Biocon Limited's employer brand? To edit company information,
claim this page for free
View in video summary
We are a global biopharmaceutical company which believes that everyone has a right to affordable quality medicines.
Powered by advanced therapy platforms, our 13,500+ employees blend heart, science and creativity to make better healthcare solutions.
Our 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation.
We have leveraged India’s value advantage of unmatched scientific talent and cost-competitive manufacturing to deliver scale, speed and quality. By making medicines more easily accessible for patients across the globe, we’re working towards achieving health equity.
We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines.
We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.
Mission: To be an integrated biotechnology enterprise of global distinction. Essential to this mission is excellence in:
Intellectual asset creation through discovery, research and development
State-of-the-art manufacturing capabilities
Internationally benchmarked quality and regulatory systems
New medical insight through disease-specific clinical research
Customer relationship through outstanding products and services
Human resource development through training, mentoring and empowering
Management of research and business partnerships
Vision: To enhance global healthcare through innovative and affordable biopharmaceuticals for patients, partners and healthcare systems across the globe.
Managing your company's employer brand?
Claim this Company Page for FREE
Brands of Biocon
Biocon Research
4.1
• 63 reviews
Biocon Foundation
2.0
• 11 reviews
Biocon Limited Ratings
based on 2k reviews
Overall Rating
3.9/5
How AmbitionBox ratings work?
5
856
4
649
3
295
2
113
1
136
Category Ratings
3.8
Job security
3.8
Work-life balance
3.7
Company culture
3.7
Skill development
3.6
Salary
3.6
Work satisfaction
3.1
Promotions
Biocon Limited is rated 3.9 out of 5 stars on AmbitionBox, based on 2k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Biocon Limited
based on 2k reviews
3.9
Rated by 302 Women
Rated 3.8 for Job security and 3.7 for Work-life balance
4.0
Rated by 1.7k Men
Rated 3.8 for Work-life balance and 3.8 for Company culture
Work Policy at Biocon Limited
based on 276 reviews in last 6 months
Work from office
82%
Hybrid
15%
Permanent work from home
3%
Biocon Limited Reviews
Top mentions in Biocon Limited Reviews
+ 5 more
UL Solutions
We're passionate about making work-life balance your reality.
Compare Biocon Limited with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.9/5 based on 2k reviews | 3.7/5 based on 740 reviews | 3.8/5 based on 874 reviews | 3.6/5 based on 940 reviews |
Highly Rated for | Work-life balance Job security | No highly rated category | Job security Work-life balance Company culture | No highly rated category |
Critically Rated for | Promotions | Promotions Job security | Promotions | Promotions Work satisfaction Work-life balance |
Primary Work Policy | Work from office 82% employees reported | Work from office 71% employees reported | Hybrid 53% employees reported | Work from office 79% employees reported |
Rating by Women Employees | 3.9 Good rated by 302 women | 3.4 Average rated by 64 women | 4.0 Good rated by 248 women | 3.4 Average rated by 176 women |
Rating by Men Employees | 4.0 Good rated by 1.7k men | 3.7 Good rated by 629 men | 3.8 Good rated by 579 men | 3.6 Good rated by 732 men |
Job security | 3.8 Good | 3.3 Average | 3.9 Good | 3.3 Average |
View more
Biocon Limited Salaries
Biocon Limited salaries have received with an average score of 3.6 out of 5 by 2k employees.
Junior Executive
(543 salaries)
Unlock
₹2 L/yr - ₹5.1 L/yr
Deputy Manager
(442 salaries)
Unlock
₹7 L/yr - ₹18 L/yr
Executive Production
(266 salaries)
Unlock
₹3 L/yr - ₹6.1 L/yr
Senior Scientist
(235 salaries)
Unlock
₹4.8 L/yr - ₹11.5 L/yr
Principal Scientist
(159 salaries)
Unlock
₹6 L/yr - ₹15.1 L/yr
Scientist
(108 salaries)
Unlock
₹2.8 L/yr - ₹6.5 L/yr
Executive Engineer
(106 salaries)
Unlock
₹3.3 L/yr - ₹6.3 L/yr
Territory Business Manager
(85 salaries)
Unlock
₹3.4 L/yr - ₹7.6 L/yr
QC Executive
(84 salaries)
Unlock
₹2.7 L/yr - ₹5.3 L/yr
Associate Scientific Manager
(56 salaries)
Unlock
₹9.1 L/yr - ₹19.1 L/yr
Biocon Limited Interview Questions
Interview questions by designation
Top Biocon Limited interview questions and answers
Get interview-ready with top interview questions
Biocon Limited Jobs
Popular Skills Biocon Limited Hires for
Current Openings
Biocon Limited News
View all
Buzzing stocks: Infosys, Biocon, Royal Orchids, PVP Ventures, Rajesh Power, Spandana Sphoorty
- Biocon's board has approved raising up to Rs 4,500 crore through the issuance of securities.
- Royal Orchid Hotels has launched 'Regenta Bharti Resort' in Mahabaleshwar, Maharashtra.
- Uma Exports is set to enter into manufacturing of pulses with a proposed capacity addition of 36,000 MTPA.
- PVP Ventures has acquired 52% stake in Biohygea Global Private Limited to build a global Healthcare Services platform.
HinduBusinessLine | 24 Apr, 2025
Stocks To Watch: Bajaj Finance, Gensol Engineering, Biocon And More
- Stocks like Bajaj Finance, Gensol Engineering, Biocon, Central Bank of India, Adani Green, and NHPC, among others, are in focus for upcoming trade.
- Bajaj Finance is contemplating a stock split and bonus issue on April 29, 2025.
- Gensol Engineering clarified no association with Mahadev Book app case. Biocon plans to raise funds up to Rs 4,500 crore.
- Central Bank of India is considering fund-raising options via QIP or preferential issue.
- Adani Green's arm inked a deal with Uttar Pradesh Power Corp for energy storage supply.
- NHPC to develop a 1,200 MW solar park in Uttar Pradesh and invest in Bundelkhand Saur Urja for the same project.
- Various companies like Panacea Biotec, 360 One WAM, Niva Bupa Health, and others have important developments.
- Q4 earnings by companies like Tata Consumer Products, LTIMindtree, Tamilnad Mercantile Bank, and more show varied financial performances.
- Companies such as Bajaj Housing Finance, Can Fin Homes, Supreme Petrochem, Thyrocare Tech, and others reported their Q4 results.
- Several companies like Dalmia Bharat, Astec Lifesciences, and Rallis India showcased their financial results for Q4.
Bloomberg Quint | 24 Apr, 2025
Stock Market Today: All You Need To Know Going Into Trade On April 21
- India's benchmark equity indices closed higher for the third consecutive session on Thursday, with NSE Nifty 50 rising 1.77% and BSE Sensex going up by 1.96% to record their best week in four years.
- Foreign portfolio investors continued to be net buyers of Indian equities while domestic institutional investors were net sellers on Thursday.
- Several notable earnings reports included HDFC Bank, ICICI Bank, Yes Bank, HDFC Life Insurance, Infosys, and Tata Elxsi, among others.
- Stocks to watch included Jubilant Pharmova, Shree Cement, Biocon, BHEL, Vedanta, Cipla, Divi’s Laboratories, and National Fertilizers, among others.
- In trading tweaks, price band changes were noted for Diffusion Engineers, while Nifty April Futures saw an increase and a fall in open interest.
- The Indian rupee appreciated by 31 paise against the US dollar, closing at 85.38, supported by foreign inflows and stable market sentiment.
- Key developments in bulk deals and trading tweaks were observed for Coforge, Fusion Finance, Hathway Cable & Datacom, and others in the market.
- Overall, the stock market witnessed positive movements, with key indices performing well and notable corporate updates impacting investor sentiment.
- Various sectors and companies reported financial results, strategic investments, product launches, and regulatory approvals, influencing market dynamics.
- The market closed amidst a positive outlook, with key highlights including the rupee's appreciation, trading cues, and notable moves in the stock market.
- In the midst of several corporate actions and market developments, investors remained attentive to earnings reactions, stock movements, and upcoming board meetings.
Bloomberg Quint | 21 Apr, 2025
Stock Market Today: All You Need To Know Going Into Trade On April 11
- Stock markets globally were impacted by a steep escalation in the US-China trade war which led to a sharp decline in Asian and US markets.
- Indian equity indices closed in the red as investors reacted to the RBI rate cut and ongoing trade tensions.
- TCS reported Q4 FY25 results with revenue up, but net profit and margin slightly down.
- Stocks to watch include Tata Steel, Infosys, Sanofi India, NBCC, and BHEL, among others, with various developments and announcements.
- Companies like Welspun Corp, Biocon, GAIL, JSW Energy, and Sun Pharma made significant moves and announcements in various sectors.
- Currency market update saw the rupee weakening against the US dollar amid global risk aversion and domestic policy cues.
- Research reports previewing Q4 results for Zomato, Swiggy, Nykaa, cement, specialty chemicals, hotels, metals, and more were discussed.
- Various trading tweaks, block deals, and F&O cues, along with market updates and expert stock insights, were highlighted.
- Overall, the stock market showed volatility influenced by global trade tensions, company earnings, and market developments.
- Investors need to remain cautious and informed about market movements and company-specific events for strategic decision-making.
Bloomberg Quint | 11 Apr, 2025
Stock Market Today: All You Need To Know Going Into Trade On Feb. 25
- Indian benchmark indices closed lower on Monday, with Nifty at 22,553.35 and Sensex at 74,454.41, marking their longest losing streak since November 1996.
- Foreign portfolio investors sold Indian equities worth Rs 6,286.7 crore while domestic institutional investors bought equities worth Rs 5,185.7 crore.
- The Indian rupee ended flat at 86.71 per dollar after erasing early gains, following a slump in US business activity.
- Stocks to watch include ONGC, NTPC, Firstsource Solutions, and Biocon, among others, with updates on their investments and developments.
- Trading tweaks included price band changes, stocks trading ex-dividend, and movements in the ASM framework for various companies.
- In F&O cues, Nifty futures were down, open interest decreased, and key levels for Options Feb. 27 Expiry were at 23,000 and 22,500.
- Bulk deals saw Quality Power Electrical Equipments and Pentateam Inventure Capital involved in significant share transactions.
- Insider trades included acquisitions by promoters in NCL Industries, Alembic Pharma, and KCP, among others.
- Scheduled meetings between companies and investors/analysts for Fino Payments Bank, Axis Bank, and others were announced.
- The Indian rupee finished flat against the US dollar at 86.71, witnessing pressure due to weakening US business activity.
Bloomberg Quint | 25 Feb, 2025
Biocon Board Okays Issuing Of Commercial Papers Worth Rs 570 Crore
- Biocon Ltd. plans to raise Rs 570 crore through the issuance of commercial papers on a private placement basis.
- Commercial papers are short-term, unsecured debt obligations issued as an alternative to costlier funding methods.
- Biocon has also achieved an improvement in its Environmental, Social, and Governance (ESG) scores, with an S&P Global ESG score of 69 in 2024.
- This places Biocon in the 98th percentile among its global biotechnology industry peers.
Bloomberg Quint | 27 Jan, 2025
"Tragic to See This Happen,” Biocon Chief Regrets as Fire at Bengaluru’s Startup Hub Causes Loss of Rs 150 Cr
- A massive fire at the Bangalore Bioinnovation Centre (BBC) in Electronics City caused a loss of around Rs 150 crore.
- Karnataka IT-BT minister Priyank Kharge expressed commitment to helping affected startups rebuild.
- Biocon Limited Executive Chairperson Kiran Mazumdar-Shaw expressed regret and emphasized the need for fire preparedness.
- Startups at the BBC have incurred losses ranging from Rs 80 crore to Rs 110 crore, with damage to BBC properties around Rs 42 crore.
Startup Pedia | 16 Jan, 2025
F&O Query: Should you hold Biocon put option?
- Biocon stock has been moving in a sideways trend since July last year, with a resistance at ₹385-₹395.
- The stock is currently trading near the upper end of the range and could see a drop to ₹325, with support at ₹350.
- Holding the 320-put option is recommended as the stock may decline soon, but a drop below ₹320 is less likely.
- If the stock declines to ₹350-₹335 in about a week, the 320-put option's premium could rise to ₹1-₹3 with a target of ₹2.
HinduBusinessLine | 9 Jan, 2025
The Fifth Episode of Crafting Bharat: Deep Tech with Fermbox Bio
- India's bioeconomy has witnessed a surge from US$10 billion in 2014 to over US$130 billion in 2024.
- Fermbox Bio is pioneering precision fermentation as India's tech ecosystem flourishes.
- Fermbox Bio is building a million-litre fermentation facility in Thailand in partnership with BBGI.
- Fermbox Bio's goal is to disrupt global fermentation by focusing on collaboration and scalability.
- Nithish Kumar from Speciale Invest interviews Fermbox Bio's Subramani Ramachandrappa in this episode.
- They discuss the complexities of the biotech sector and what precision fermentation means.
- Fermbox Bio makes enzymes free of animal derivatives to make vaccines safer.
- Subramani Ramachandrappa left Biocon to start his entrepreneurial journey with Richcore.
- Richcore was later acquired by Laurus Labs, paving the way for the establishment of Fermbox Bio.
- Subramani Ramachandrappa believes biotech's future will lie in openness and partnerships.
VIE Stories | 4 Jan, 2025
Stock Market Live Updates 3 January 2025: Stock to buy today: Mahindra & Mahindra (₹3,210) BUY
- Benchmark indices rose over 1.8 per cent on Thursday, led by strong buying in index heavyweights.
- The Sensex settled at 79,943, up 1,436 points or 1.83 per cent from its previous close.
- The Nifty50 ended at 24,188, up 445 points or 1.88 per cent.
- Smallcap 100 Index posted a more modest gain of 0.64 per cent.
- Strong buying was seen in heavyweights especially auto, NBFCs and IT stocks, driven by optimism about upcoming quarterly earnings.
- DMart added 10 stores during the quarter, taking the count to 387 stores.
- Shaily Innovations FZCO, in Dubai, UAE, will be engaged in contracts involving design and development of drug delivery devices.
- NHPC received Rs 250 crore as the second installment of gross payment under a mega insurance policy.
- Biocon receives NMPA approval for Tacrolimus capsules in China.
- Deepak Builders saw CRISIL upgrading the company's long term rating to BBB+.
HinduBusinessLine | 3 Jan, 2025
Powered by
Biocon Limited Offices
Compare Biocon Limited with
LifeCell International
3.4
Praj Industries
4.1
Serum Institute of India
4.1
Bharat Biotech International
3.1
Transasia Bio-Medicals
3.3
Indian Immunologicals
4.1
Jubilant Biosys
3.8
Avantor
3.5
Aurigene Oncology Limited
4.3
Cryoviva Biotech
3.3
Novozymes South Asia
4.1
Biotique
3.5
Fermenta Biotech
4.3
dsm-firmenich
4.0
Eurofins Scientific
3.3
Kemwell Biopharma
3.6
Shivashakti Bio Technologies
4.2
Sartorius Stedim India
3.9
Pall Corporation
4.2
MilliporeSigma
3.9
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Write a review
Share interview
Contribute salary
Add office photos
Companies Similar to Biocon Limited
Thermo Fisher Scientific
Biotech & Life sciences, Internet, Analytics & KPO, Biotechnology, Pharma
3.8
• 874 reviews
Biocon Biologics
Biotechnology
3.6
• 940 reviews
Panacea Biotec
Biotech & Life sciences, Biotechnology
3.7
• 740 reviews
LifeCell International
Biotech & Life sciences, Internet, Biotechnology
3.4
• 653 reviews
Praj Industries
Biotech & Life sciences, Biotechnology
4.1
• 616 reviews
Serum Institute of India
Biotechnology
4.1
• 484 reviews
Bharat Biotech International
Biotech & Life sciences, Manufacturing, Biotechnology
3.1
• 468 reviews
Transasia Bio-Medicals
Industrial Machinery, Biotechnology
3.3
• 376 reviews
Indian Immunologicals
Biotech & Life sciences, Manufacturing, Biotechnology
4.1
• 367 reviews
Jubilant Biosys
Financial Services, Biotechnology
3.8
• 319 reviews
Avantor
Chemicals / Agri Inputs, Biotechnology, Healthcare, Pharma
3.5
• 272 reviews
Aurigene Oncology Limited
Biotech & Life sciences, Biotechnology
4.3
• 262 reviews
Biocon Limited FAQs
When was Biocon Limited founded?
Biocon Limited was founded in 1978. The company has been operating for 47 years primarily in the Biotechnology sector.
Where is the Biocon Limited headquarters located?
Biocon Limited is headquartered in Bangalore Rural, Karnataka.
How many employees does Biocon Limited have in India?
Biocon Limited currently has more than 3,600+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in Biocon Limited based on the number of reviews submitted on AmbitionBox.
Does Biocon Limited have good work-life balance?
Biocon Limited has a Work-Life Balance Rating of 3.8 out of 5 based on 2,000+ employee reviews on AmbitionBox. 73% employees rated Biocon Limited 4 or above, while 27% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Biocon Limited work-life balance reviews for more details
Is Biocon Limited good for career growth?
Career growth at Biocon Limited is rated as moderate, with a promotions and appraisal rating of 3.1. 27% employees rated Biocon Limited 3 or below, while 73% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Biocon Limited promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Biocon Limited?
Working at Biocon Limited comes with several advantages and disadvantages. It is highly rated for job security and work life balance. However, it is poorly rated for promotions / appraisal, based on 2,000+ employee reviews on AmbitionBox.
Recently Viewed
JOBS
Browse jobs
Discover jobs you love
SALARIES
Google
No Salaries
LIST OF COMPANIES
Cybage
Overview
JOBS
TransUnion
No Jobs
LIST OF COMPANIES
Torana
Overview
COMPANY BENEFITS
Sporjo
No Benefits
COMPANY BENEFITS
Zostel
No Benefits
LIST OF COMPANIES
Sporjo
Overview
COMPANY BENEFITS
Cybage
No Benefits
SALARIES
Cybage
No Salaries
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
